Indian pharma market grew 12.1% in value during August

Indian pharmaceutical market (IPM) grew 12.1% in value and 4.8% in volumes, in the month of August on back of strong growth across all the therapy areas, according to a research...

Cipla, JB Chemicals & Torrent lead Rs 4,500-crore race for Medley Pharma

Cipla, KKR-owned JB Chemicals and Torrent Pharmaceuticals are in the final race for acquiring Medley Pharmaceuticals in a deal worth around ₹4,500 crore, said people aware of the development. Half a dozen bids were in for Medley, including bids...

Frederic Oudea to be Sanofi's non-executive chairman

The appointment of Societe Generale's boss Frederic Oudea as non-executive chairman of Sanofi will be proposed at the next shareholders meeting of the French drugs group, Sanofi said....

UK approved second 'bivalent' booster for Omicron & original COVID strain

The UK health authorities approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19...

Three Crucial Benefits of Leveraging Real-World Evidence in Pharma

RWE helps researchers understand how patient characteristics and behaviors affect health outcomes, which helps to predict the progression of a disease and a patient’s response to a vaccine or therapy.

Centre gives approval for 3 bulk drug parks in Gujarat, HP and AP

According to the Ministry of Chemicals and Fertilizers, the Government of India has given "in-principle" clearance for the construction of three bulk drug parks, one in each of Himachal Pradesh, Gujarat, and Andhra Pradesh. The proposals from Hima...

PCD Pharma Franchises and their growing influence in Pharma Industry

Acknowledging this scenario, many PCD phrama franchises have started to open their own manufacturing units with the necessary certifications. This can not only help pharma companies to overcome supply chain issues but it can also help them to remo...

Alembic Pharmaceuticals Gujarat facility recieves observations from USFDA

Alembic Pharmaceuticals said the US health regulator has issued Form 483 with two observations for its injectable facility at Karkhadi in Gujarat, following an inspection....

Zydus gets nod from USFDA for Venlafaxine and Pregabalin tablets

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market two medicines: Venlafaxine extended-release tablets, USP 37.5 mg, 75 mg, 150 mg and 225 mg; and Pregabalin...

Aurobindo Pharma subsidiary's plant gets one observation from USFDA

Aurobindo Pharma said the US health regulator has issued one observation after inspecting a plant owned by its US-based unit...

© 2025 India Pharma Outlook. All Rights Reserved.